Location History:
- Ayase, JA (1976)
- Ayase, JP (1985 - 2003)
Company Filing History:
6 out of 21 
3 out of 44 
2 out of 212 Years Active: 1976-2003
Title: The Innovative Contributions of Tsutomu Sawa
Introduction
Tsutomu Sawa is a notable inventor based in Ayase, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work primarily focuses on the development of novel compounds with therapeutic applications.
Latest Patents
Among his latest patents are salicylamide derivatives, which are represented by specific formulae. These derivatives serve as intermediates in their production and are useful as anti-inflammatory and immunosuppressive agents. They inhibit the activation of NF-κB with minimal side effects. Another significant invention is the anticancer antibiotic MI43-37F11 substance. This compound exhibits antitumor activity and enhances the production of interleukin-1 in mammals. It can be produced by cultivating the Streptoverticillium eurocidicum MI43-37F11 strain, identified as FERM BP-2783.
Career Highlights
Tsutomu Sawa has worked with several organizations throughout his career. Notably, he has been associated with Sanraku Incorporated and the Microbial Chemistry Research Foundation. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Throughout his career, Sawa has collaborated with esteemed colleagues, including Tomio Takeuchi and Hamao Umezawa. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.
Conclusion
Tsutomu Sawa's contributions to pharmaceutical innovations are noteworthy, particularly in the development of compounds with significant therapeutic potential. His work continues to impact the field positively, showcasing the importance of research and collaboration in advancing medical science.